Bayesian Capital Management, LP Amylyx Pharmaceuticals, Inc. Transaction History

Bayesian Capital Management, LP

  • $854 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$20.98 - $31.42 $132,174 - $197,946
-6,300 Reduced 38.53%
10,050 $216,000
Q1 2023

May 15, 2023
BUY
$27.71 - $40.93 $45,721 - $67,534
1,650 Added 11.22%
16,350 $479,000
Q4 2022

Feb 14, 2023
BUY
$29.75 - $39.26 $437,325 - $577,122
14,700 New
14,700 $543,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email